Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Harte Hanks (HHS) Restructuring Costs (2019 - 2025)

Harte Hanks has reported Restructuring Costs over the past 6 years, most recently at $282000.0 for Q4 2025.

  • Quarterly Restructuring Costs fell 1.4% to $282000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Dec 2025, down 27.3% year-over-year, with the annual reading at $1.8 million for FY2025, 25.81% down from the prior year.
  • Restructuring Costs was $282000.0 for Q4 2025 at Harte Hanks, down from $538000.0 in the prior quarter.
  • Over five years, Restructuring Costs peaked at $5.7 million in Q4 2023 and troughed at $100000.0 in Q2 2025.
  • The 4-year median for Restructuring Costs is $800000.0 (2024), against an average of $1.3 million.
  • Year-over-year, Restructuring Costs soared 60.91% in 2021 and then plummeted 94.97% in 2024.
  • A 4-year view of Restructuring Costs shows it stood at $1.9 million in 2021, then surged by 199.32% to $5.7 million in 2023, then plummeted by 94.97% to $286000.0 in 2024, then fell by 1.4% to $282000.0 in 2025.
  • Per Business Quant, the three most recent readings for HHS's Restructuring Costs are $282000.0 (Q4 2025), $538000.0 (Q3 2025), and $100000.0 (Q2 2025).